Patents by Inventor Mathias Seeliger

Mathias Seeliger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene therapy for the treatment of a retinal degeneration disease
    Patent number: 11400167
    Abstract: The present invention relates to a polynucleotide configured for the treatment of a retinal degeneration disease, such as retinitis pigmentosa (RP), a nucleic acid vector comprising said polynucleotide, a pharmaceutical composition comprising said nucleic acid vector, a kit comprising said polynucleotide or said nucleic acid vector, a method of making said nucleic acid vector, and a method for treating a retinal degeneration disease.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: August 2, 2022
    Assignee: EYESERV GMBH
    Inventors: Stylianos Michalakis, Martin Biel, Mathias Seeliger, Christian Schoen
  • Gene therapy for the treatment of a disease of retinal cone cells
    Patent number: 10849991
    Abstract: The present invention relates to a polynucleotide configured for the treatment of a disease of retinal cone cells, such as achromatopsia, a nucleic acid vector comprising said polynucleotide, a pharmaceutical composition comprising said nucleic acid vector, a kit comprising said polynucleotide or said nucleic acid vector, a method of making said nucleic acid vector, and a method for treating a disease of the retinal cone cells.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: December 1, 2020
    Assignee: EyeServ GmbH
    Inventors: Stylianos Michalakis, Martin Biel, Mathias Seeliger
  • GENE THERAPY FOR THE TREATMENT OF A RETINAL DEGENERATION DISEASE
    Publication number: 20180353620
    Abstract: The present invention relates to a polynucleotide configured for the treatment of a retinal degeneration disease, such as retinitis pigmentosa (RP), a nucleic acid vector comprising said polynucleotide, a pharmaceutical composition comprising said nucleic acid vector, a kit comprising said polynucleotide or said nucleic acid vector, a method of making said nucleic acid vector, and a method for treating a retinal degeneration disease.
    Type: Application
    Filed: August 22, 2018
    Publication date: December 13, 2018
    Inventors: Stylianos Michalakis, Martin Biel, Mathias Seeliger, Christian Schoen
  • GENE THERAPY FOR THE TREATMENT OF A DISEASE OF RETINAL CONE CELLS
    Publication number: 20180353619
    Abstract: The present invention relates to a polynucleotide configured for the treatment of a disease of retinal cone cells, such as achromatopsia, a nucleic acid vector comprising said polynucleotide, a pharmaceutical composition comprising said nucleic acid vector, a kit comprising said polynucleotide or said nucleic acid vector, a method of making said nucleic acid vector, and a method for treating a disease of the retinal cone cells.
    Type: Application
    Filed: August 22, 2018
    Publication date: December 13, 2018
    Inventors: Stylianos Michalakis, Martin Biel, Mathias Seeliger